| Literature DB >> 23983637 |
Carla Nicola1, Mirian Salvador, Adriana Escalona Gower, Sidnei Moura, Sergio Echeverrigaray.
Abstract
The present work aimed to analyze the alkaloid content of the ethanolic extract of Tabernaemontana catharinensis (Apocynaceae family) and its fractions as well as to evaluate their antioxidant and anticholinesterasic activities. The analyses of the ethanolic extract of T. catharinensis by mass spectrometry allowed identifying the presence of the alkaloids 16-epi-affinine, coronaridine-hydroxyindolenine, voachalotine, voacristine-hydroxyindolenine, and 12-methoxy-n-methyl-voachalotine, as well as an alkaloid with m/z 385.21 whose spectrum suggests a derivative of voacristine or voacangine. The extract and its alkaloid rich fractions showed antioxidant activity, especially those that contain the alkaloid m/z 385.21 or 16-epi-affinine with DPPH scavenging activity (IC50) between 37.18 and 74.69 μg/mL. Moreover, the extract and its fractions exhibited anticholinesterasic activity, particularly the fractions characterized by the presence of 12-methoxy-n-methyl-voachalotine, with IC50 = 2.1 to 2.5 μg/mL. Fractions with 16-epi-affinine combined good antioxidant (IC50 = 65.59 to 74.69 μg/mL) and anticholinesterasic (IC50 = 7.7 to 8.3 μg/mL) activities, representing an option for further studies aimed at treating neurodegenerative diseases.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23983637 PMCID: PMC3745974 DOI: 10.1155/2013/519858
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Diagram of fractionation of Tabernaemontana catharinensis extract.
Figure 2Electrospray positive spectra of T. catharinensis extract and structures of identified alkaloids compounds.
Chemical composition of T. catharinensis extract by ESI(+)-MS e ESI(+)-MS/MS.
| Entry | Precursor | Fragmentation | Identification | Elem. comp. | Diff. ppm | Fragmentation pathways | References |
|---|---|---|---|---|---|---|---|
| 1 | 309.1963 | 291.1864(35); 202.1232(5); 158.0968(17); 138.0917(16) | Affinisine | C20H24N2O | 0.646 | 291.1864[M-OH]; 202.1232[M-C7H8N]; | [ |
|
| |||||||
| 2 | 325.1918 | 308.1891(15); 307.1814(13) [289.1706(4); 265.1700(100) | 16-epi-Affinine | C20H24N2O2 | 2.460 | 308.1891[M-OH]; 265.1700[M-C2H3O2]; 152.1074[M-C11H10NO] | [ |
|
| |||||||
| 3 | 353.1866 | 322.1443(9); 321.1606(33), [293.1654(65), 275.1548(22) | Vobasine | C21H24N2O3 | 1.981 | 322.1443[M-C2H6]; | [ |
|
| |||||||
| 4 | 355.2023 | 337.1920(100) [305.1656(60); 277.1706(21); 216.1024(8); 144.0811(9)]; 323.1762(7); 305.1657(60) [290.1418(22); 277.1704(100) {207.0921(10)}; 235.0869(67); 184.0760(36); 174.0916(33)] | Coronaridine-hydroxyindolenine | C21H26N2O3 | 1.970 | 337.1920[M-OH]; 323.1762[M-CH3O] 305.1657[M-CH4O2]; 277.1704[M-C2H5O3] | [ |
|
| |||||||
| 5 | 367.2023 | 337.1921(100) [305.1655(28); 172.1125(16); 158.0967(34)]; 335.1765(7); 305.1658(23); 172.1126(31); 166.0868(5); 158.0969(7) | Voachalotine | C22H26N2O3 | 1.906 | 337.1921[M-CH3OH]; | [ |
|
| |||||||
| 6 | 385.2128 | 367.2024(100), [335.1761(100), {307.1812(40), 265.0977(21), 214.0867(9), 174.0917(15)}; 307.1810(100) 246.1130(19); 174.0918(10)]; 335.1765(20); 307.1815(7) | Derivative of voacristine or voacangine | n.d | |||
|
| |||||||
| 7 | 401.2075 | 383.1975(100) [365.1867(100); {333.1604(20); 201.1026(26)} | Voacristine- | C22H28N2O5 | 1.246 | 383.1975[M-OH]; | [ |
|
| |||||||
| 8 | 411.2283 | 381.2181(100); 349.1917(100); [334.1681(16); 321.1966(10); 317.1654(15); 266.1544(35); {251.1309(21); 237.1151(44)}]; 200.1076(100); [185.0839(14); 169.0890(12)]; 180.1024(25) | 12-Methoxy-n-methyl-voachalotine | C24H31N2O4 | 1.215 | 381.2181[M-CH4O]; 349.1917[M-C2H6O2] 334.1681[M-C3H8O2]; 321.1966[M-C3H7O3] 200.1076[M-C11H15NO3] | [ |
|
| |||||||
| 9 | 415.2126 | ni | |||||
ni: not identificated.
Figure 3ESI(+)-MS/MS of affinisine.
Figure 42 Electrospray positive spectra of fractions B1–B3, C1–C6.
Antioxidant and anticholinesterasic activity of T. catharinensis extract and fractions.
| Samples | DPPH-IC50 ( | AChE inhibition-IC50 ( |
|---|---|---|
| Extract | 313.46 ± 0.5b | 261.55 ± 9.1b |
| Organic/aqueus fractions | ||
| B1 | 1590.00 ± 1.4a | 458.40 ± 8.2a |
| B2 | 60.75 ± 0.5e | 18.35 ± 1.4d |
| B3 | 67.28 ± 0.6e | 9.0 ± 0.4e |
| c. column fractions | ||
| C1 | 94.92 ± 0.05d | 17.35 ± 1.4d |
| C2 | 37.18 ± 0.1f | 91.22 ± 7.1c |
| C3 | 74.69 ± 0.9e | 7.71 ± 0.1e |
| C4 | 65.59 ± 0.3e | 8.34 ± 0.6e |
| C5 | 230.25 ± 0.1c | 2.50 ± 0.1f |
| C6 | 249.61 ± 0.9c | 2.10 ± 0.1f |
| Ascorbic acid | 20.13 ± 0.45g | — |
| Galantamine | — | 0.2 ± 0.05g |
Different letters correspond to values statistically different by analysis of variance (ANOVA) and Tukey's post hoc test, for P ≤ 0.05, for each activity.
Figure 5Kinetic study of inhibition of acetylcholinesterase by C6 fraction and galantamine (standard acetylcholinesterase inhibitor). (a) Michaelis-Menten kinetic for C6 fraction, (b) double reciprocal (Lineweaver Burk) plot for C6 fraction, and (c) double reciprocal (Line-weaver Burk) plot for galantamine.